TPH2 inhibitors (Max Delbruck Centrum)

N/A

Report date: 2025/03/19 18:27:01
NME

Base Information

Drug NameTPH2 inhibitors (Max Delbruck Centrum)
Drug Alias Nametryptophan hydroxylase 2 inhibitors (Max Delbruck Centrum/Ascenion)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTryptophan hydroxylase 2 inhibitors
TargetsTryptophan hydroxylase 2
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMax Delbruck Centrum Fur Molekulare Medizin
China Registration ClassN/A

Develop Information

Active CompaniesMax Delbruck Centrum Fur Molekulare MedizinAscenion
Inactive CompaniesN/A
Active IndicationsMental Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A